Literature DB >> 17907865

Meta-analysis of day treatment and contingency-management dismantling research: Birmingham Homeless Cocaine Studies (1990-2006).

Joseph E Schumacher1, Jesse B Milby, Dennis Wallace, Dawna-Cricket Meehan, Stefan Kertesz, Rudy Vuchinich, Jonathan Dunning, Stuart Usdan.   

Abstract

Four successive randomized clinical trials studying contingency management (CM), involving various treatment arms of drug-abstinent housing and work therapy and day treatment (DT) with a behavioral component, were compared on common drug abstinence outcomes at 2 treatment completion points (2 and 6 months). The clinical trials were conducted from 1990 to 2006 in Birmingham, Alabama, with a total of 644 homeless persons with primary crack cocaine addiction. The meta-analysis utilized the weighted least squares approach to integrate data encompassing 9 different treatment arms to assess the effects of CM and DT (neither, DT only, CM only, and CM = DT) on a common estimate of prevalence of drug abstinence. Taken together, the results show much stronger benefits from CM = DT and from CM only than for DT alone. Throughout all of the Birmingham Homeless Cocaine Studies, the CM = DT consistently produced higher abstinence prevalence than did no CM. (PsycINFO Database Record (c) 2007 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17907865     DOI: 10.1037/0022-006X.75.5.823

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  26 in total

1.  Contingency Management Reduces Symptoms of Psychological and Emotional Distress among Homeless, Substance-dependent Men Who Have Sex with Men.

Authors:  Jesse B Fletcher; Steven Shoptaw; James A Peck; Cathy J Reback
Journal:  Ment Health Subst Use       Date:  2014-11-01

2.  Effects of experimental Unemployment, Employment and Punishment analogs on opioid seeking and consumption in heroin-dependent volunteers.

Authors:  Mark K Greenwald
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

Review 3.  Contingency management treatment for substance use disorders: How far has it come, and where does it need to go?

Authors:  Nancy M Petry; Sheila M Alessi; Todd A Olmstead; Carla J Rash; Kristyn Zajac
Journal:  Psychol Addict Behav       Date:  2017-06-22

4.  Prize-based contingency management for the treatment of substance abusers: a meta-analysis.

Authors:  Lois A Benishek; Karen L Dugosh; Kim C Kirby; Jason Matejkowski; Nicolle T Clements; Brittany L Seymour; David S Festinger
Journal:  Addiction       Date:  2014-05-23       Impact factor: 6.526

5.  The costs of crime associated with stimulant use in a Canadian setting.

Authors:  Benjamin Enns; Emanuel Krebs; Kora DeBeck; Kanna Hayashi; M-J Milloy; Lindsey Richardson; Evan Wood; Bohdan Nosyk
Journal:  Drug Alcohol Depend       Date:  2017-09-14       Impact factor: 4.492

6.  Pharmacotherapeutic strategies for treating cocaine use disorder-what do we have to offer?

Authors:  Laura Brandt; Thomas Chao; Sandra D Comer; Frances R Levin
Journal:  Addiction       Date:  2020-09-28       Impact factor: 6.526

7.  Adaptability of contingency management in justice settings: survey findings on attitudes toward using rewards.

Authors:  Amy Murphy; Anne Giuranna Rhodes; Faye S Taxman
Journal:  J Subst Abuse Treat       Date:  2011-12-29

Review 8.  Use of novel technology-based techniques to improve alcohol-related outcomes in clinical trials.

Authors:  Eugenia M Gurvich; George A Kenna; Lorenzo Leggio
Journal:  Alcohol Alcohol       Date:  2013-08-17       Impact factor: 2.826

9.  Effects of sustained abstinence among treated substance-abusing homeless persons on housing and employment.

Authors:  Jesse B Milby; Joseph E Schumacher; Dennis Wallace; Rudy Vuchinich; Stephen T Mennemeyer; Stefan G Kertesz
Journal:  Am J Public Health       Date:  2009-10-15       Impact factor: 9.308

10.  Addiction treatment and stable housing among a cohort of injection drug users.

Authors:  Anita Palepu; Brandon D L Marshall; Calvin Lai; Evan Wood; Thomas Kerr
Journal:  PLoS One       Date:  2010-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.